116 related articles for article (PubMed ID: 20731868)
1. Stromal genes add prognostic information to proliferation and histoclinical markers: a basis for the next generation of breast cancer gene signatures.
Mefford D; Mefford J
PLoS One; 2012; 7(6):e37646. PubMed ID: 22719844
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel mitosis regulators through data mining with human centromere/kinetochore proteins as group queries.
Tipton AR; Wang K; Oladimeji P; Sufi S; Gu Z; Liu ST
BMC Cell Biol; 2012 Jun; 13():15. PubMed ID: 22712476
[TBL] [Abstract][Full Text] [Related]
3. Enumerating the gene sets in breast cancer, a "direct" alternative to hierarchical clustering.
Mefford D; Mefford JA
BMC Genomics; 2010 Aug; 11():482. PubMed ID: 20731868
[TBL] [Abstract][Full Text] [Related]
4. The molecular portraits of breast tumors are conserved across microarray platforms.
Hu Z; Fan C; Oh DS; Marron JS; He X; Qaqish BF; Livasy C; Carey LA; Reynolds E; Dressler L; Nobel A; Parker J; Ewend MG; Sawyer LR; Wu J; Liu Y; Nanda R; Tretiakova M; Ruiz Orrico A; Dreher D; Palazzo JP; Perreard L; Nelson E; Mone M; Hansen H; Mullins M; Quackenbush JF; Ellis MJ; Olopade OI; Bernard PS; Perou CM
BMC Genomics; 2006 Apr; 7():96. PubMed ID: 16643655
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive profiling of biological processes reveals two major prognostic subtypes in breast cancer.
Chen F; Gao S; Wang F; Ma J; Zhang M; Lv M; Zhou Q; Fu Z; Lu C; Yin H
Tumour Biol; 2016 Mar; 37(3):3365-70. PubMed ID: 26446459
[TBL] [Abstract][Full Text] [Related]
6. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
[TBL] [Abstract][Full Text] [Related]
7. Challenges in projecting clustering results across gene expression-profiling datasets.
Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
[TBL] [Abstract][Full Text] [Related]
8. Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
Yau C; Fedele V; Roydasgupta R; Fridlyand J; Hubbard A; Gray JW; Chew K; Dairkee SH; Moore DH; Schittulli F; Tommasi S; Paradiso A; Albertson DG; Benz CC
Breast Cancer Res; 2007; 9(5):R59. PubMed ID: 17850661
[TBL] [Abstract][Full Text] [Related]
9. Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours.
Albergaria A; Paredes J; Sousa B; Milanezi F; Carneiro V; Bastos J; Costa S; Vieira D; Lopes N; Lam EW; Lunet N; Schmitt F
Breast Cancer Res; 2009; 11(3):R40. PubMed ID: 19549328
[TBL] [Abstract][Full Text] [Related]
10. High level of ezrin expression in colorectal cancer tissues is closely related to tumor malignancy.
Wang HJ; Zhu JS; Zhang Q; Sun Q; Guo H
World J Gastroenterol; 2009 Apr; 15(16):2016-9. PubMed ID: 19399936
[TBL] [Abstract][Full Text] [Related]
11. T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.
Rody A; Holtrich U; Pusztai L; Liedtke C; Gaetje R; Ruckhaeberle E; Solbach C; Hanker L; Ahr A; Metzler D; Engels K; Karn T; Kaufmann M
Breast Cancer Res; 2009; 11(2):R15. PubMed ID: 19272155
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
